The marketing authorisation was granted following a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) European…
SEIMC-GeSIDA Foundation and ViiV Healthcare announced positive 48-week results from the Paso Doble study (GeSIDA study 11720), the largest randomized…
The HIV Strategy, approved in 2023, set a target of reducing new HIV infections to fewer than 335,000 by 2030.…
CompilationThe results of pancreatic cancer treatment are usually not very encouraging for the scientific community; the tumor microenvironment of these…
CompilationPfizer today announced availability in Spain ritlecitinib (Litfulo), the first and only treatment indicated for severe alopecia areata in adults…
Gilead presented results from the third phase of the Purpose 1 clinical trial, which assessed the effectiveness of a six-month…
Moderna announced that a phase 3 study of mRNA-1083, an investigational combination flu and Covid vaccine, met its primary endpoints,…
The XXXIV Congress of the Spanish Society of Emergency Medicine (Semes), held in Seville, highlighted the success of the Deja…
Brazil is experiencing an explosive rise in dengue fever cases. A tropical disease transmitted by nasty mosquitoes Aedes aegypti and…
In the world of medicine, many promises fail due to failure in clinical trials. Very often, inventions that show great…